105
submitted 3 months ago by floofloof@lemmy.ca to c/science@lemmy.world
top 10 comments
sorted by: hot top controversial new old
[-] someguy3@lemmy.world 20 points 3 months ago

The molecule, DDL-920, works differently from recent FDA-approved drugs for Alzheimer's disease such as lecanemab and aducanumab, which remove harmful plaque that accumulates in the brains of Alzheimer's disease patients. While removing this plaque has been shown to slow the rate of cognitive decline, it does not restore memory and cognitive impairments.

"They leave behind a brain that is maybe plaqueless, but all the pathological alterations in the circuits and the mechanisms in the neurons are not corrected," Mody said.

[-] AmidFuror@fedia.io 12 points 3 months ago

Someone buy that mouse some flowers.

[-] APassenger@lemmy.world 6 points 3 months ago
[-] arcosenautic@lemmy.world 9 points 3 months ago

Anyone with a proper background would be kind enough to speculate whether this could lead to a possible cure?

[-] higgsboson@dubvee.org 8 points 3 months ago

I'm not in this field, but I mean, this one seems like all the other headlines we've read about on this topic, only for them to be dead ends. Mouse models are notoriously fraught, especially in the Alzheimer's context. Wake me up when they have treated humans in vivo.

[-] arcosenautic@lemmy.world 1 points 3 months ago

Thank you for clearing it up. Unfortunately it does seem like another research dead end

[-] redisdead@lemmy.world 3 points 3 months ago

I wouldn't call it a dead end. It's the kind of small discoveries that, when put together with all the past and future small discoveries, will eventually lead to progress.

this post was submitted on 09 Aug 2024
105 points (98.2% liked)

science

14595 readers
284 users here now

A community to post scientific articles, news, and civil discussion.

rule #1: be kind

<--- rules currently under construction, see current pinned post.

2024-11-11

founded 1 year ago
MODERATORS